Hunt J B, Thillainayagam A V, Salim A F, Carnaby S, Elliott E J, Farthing M J
Department of Gastroenterology, St Bartholomew's Hospital, West Smithfield, London.
Gut. 1992 Dec;33(12):1652-9. doi: 10.1136/gut.33.12.1652.
Controversy continues regarding the optimal composition of glucose electrolyte oral rehydration solutions for the treatment of acute diarrhoea. Four perfusion models (normal human jejunum, normal rat small intestine, cholera toxin treated secreting rat small intestine and rotavirus infected rat small intestine) have been developed and used to compare the efficacy of a hypotonic oral rehydration solution with standard United Kingdom British National formulary and developing world oral rehydration solutions (WHO). Despite obvious physiological and pathophysiological differences between these models there was general congruence in the water and solute absorption profiles of the different oral rehydration solutions. Hypotonic oral rehydration solution promoted significantly greater water absorption than other oral rehydration solutions in all rat models (p < 0.001) but apparently increased water absorption failed to achieve significance in human jejunum. British National Formulary-oral rehydration solution was unable to reverse net water secretion in both rotavirus and cholera toxin models. Net sodium absorption from hypotonic and WHO-oral rehydration solutions was significantly greater than from the low sodium British National Formulary-oral rehydration solutions (p < 0.001) except in the rotavirus model when absorption was similar to hypotonic-oral rehydration solutions. These findings show that there is agreement in the apparent efficacy of oral rehydration solutions in these animal and human perfusion models, and that improved water absorption with adequate sodium absorption may be achieved by reducing oral rehydration solution osmolality.
关于用于治疗急性腹泻的葡萄糖电解质口服补液溶液的最佳成分,争议仍在继续。已开发出四种灌注模型(正常人体空肠、正常大鼠小肠、霍乱毒素处理的分泌性大鼠小肠和轮状病毒感染的大鼠小肠),并用于比较低渗口服补液溶液与英国标准国家处方集及发展中国家口服补液溶液(世界卫生组织)的疗效。尽管这些模型之间存在明显的生理和病理生理差异,但不同口服补液溶液的水和溶质吸收情况总体一致。在所有大鼠模型中,低渗口服补液溶液促进的水吸收明显多于其他口服补液溶液(p < 0.001),但在人体空肠中,水吸收的明显增加未达到显著水平。英国国家处方集口服补液溶液在轮状病毒和霍乱毒素模型中均无法逆转净水分分泌。除了在轮状病毒模型中吸收与低渗口服补液溶液相似外,低渗和世界卫生组织口服补液溶液的净钠吸收明显高于低钠的英国国家处方集口服补液溶液(p < 0.001)。这些发现表明,在这些动物和人体灌注模型中,口服补液溶液的明显疗效是一致的,并且通过降低口服补液溶液的渗透压,可以实现更好的水吸收和足够的钠吸收。